CellaVision AB (publ) (STO:CEVI)
Sweden · Delayed Price · Currency is SEK 161.00
+2.40 (1.51%)
Feb 10, 2026, 5:29 PM CET
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 3.78 billion as of February 10, 2026. Its market cap has decreased by -25.36% in one year.
Market Cap
3.78B
Enterprise Value
3.65B
Revenue
748.45M
Ranking
n/a
PE Ratio
24.99
Stock Price
161.00
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 372.09M to 3.78B, an increase of 916.65%. That is a compound annual growth rate of 13.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 3.78B | 0.89% |
| Dec 30, 2025 | 3.75B | -27.72% |
| Dec 30, 2024 | 5.19B | 2.59% |
| Dec 29, 2023 | 5.06B | -7.42% |
| Dec 30, 2022 | 5.46B | -29.58% |
| Dec 30, 2021 | 7.76B | 5.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elekta AB | 21.17B |
| Nolato AB | 13.99B |
| Vitrolife AB | 12.30B |
| MedCap AB | 8.20B |
| Xvivo Perfusion AB | 6.33B |
| BICO Group AB | 1.23B |
| C-Rad AB | 1.06B |
| Paxman AB | 1.05B |